Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.

Manni E, Al-Kuraishy HM, Eisawy R, Abdelaziz AM, Batiha GE

DOI: 10.1007/s12031-026-02518-9
Published: 2026 Apr 24
Container: Journal of molecular neuroscience : MN
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12031-026-02518-9,
  title = {Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.},
  author = {Manni E and Al-Kuraishy HM and Eisawy R and Abdelaziz AM and Batiha GE},
  year = {2026},
  journal = {Journal of molecular neuroscience : MN},
  doi = {10.1007/s12031-026-02518-9},
  url = {https://doi.org/10.1007/s12031-026-02518-9}
}

RIS

TY  - JOUR
TI  - Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.
AU  - Manni E
AU  - Al-Kuraishy HM
AU  - Eisawy R
AU  - Abdelaziz AM
AU  - Batiha GE
PY  - 2026
JO  - Journal of molecular neuroscience : MN
DO  - 10.1007/s12031-026-02518-9
UR  - https://doi.org/10.1007/s12031-026-02518-9
ER  -

APA

E, M., HM, A., R, E., AM, A., & GE, B. (2026). Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.. Journal of molecular neuroscience : MN. https://doi.org/10.1007/s12031-026-02518-9

Source records

pubmed · retrieved 2026-09-27T11:23:15.343Z
europe-pmc · retrieved 2026-09-27T11:23:15.346Z